HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.

Abstract
We studied the TCR/CD3 complex-mediated signal transduction pathway in freshly isolated T cells and T cell lines from patients with systemic lupus erythematosus (SLE). The peak and 5-min anti-CD3 mAb-mediated free intracytoplasmic Ca2+ concentration ([Ca2+]i) increase was statistically significant higher in fresh T cells from SLE patients than in control T cells. Increased CD3-mediated [Ca2+]i responses were observed in T cells from patients with SLE but not in T cells from other rheumatic diseases. Furthermore, significantly increased CD3-mediated [Ca2+]i responses were observed in T cell lines from SLE patients but not from controls. Although the [Ca2+]i response did not correlate with the global SLE disease activity or individual clinical manifestations, it was significantly higher in the group of patients who were not on treatment. Both CD4+ and CD8+ T cell subsets from peripheral blood cells and T cell lines displayed higher CD3-mediated [Ca2+]i responses than their normal counterparts. The peak of the response occurred earlier in the patient than in the normal group. The amount of Ca2+ that was released from the intracellular stores was higher in lupus than control T cells. The TCR/CD3-induced production of inositol phosphate metabolites in SLE cells was comparable with controls. The sarcoplasmic and endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin-induced [Ca2+]i response was similar in both SLE and normal T cells. Our experiments demonstrate for the first time a definite abnormality in the early steps of the TCR/CD3-mediated signal transduction pathway in T cells from SLE patients that involves increased release of Ca2+ from intracellular stores.
AuthorsD Vassilopoulos, B Kovacs, G C Tsokos
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 155 Issue 4 Pg. 2269-81 (Aug 15 1995) ISSN: 0022-1767 [Print] United States
PMID7636273 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Receptor-CD3 Complex, Antigen, T-Cell
  • Terpenes
  • Thapsigargin
  • Inositol 1,4,5-Trisphosphate
  • Calcium
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal (immunology)
  • Calcium (metabolism)
  • Cell Line
  • Female
  • Humans
  • Inositol 1,4,5-Trisphosphate (biosynthesis)
  • Lupus Erythematosus, Systemic (metabolism)
  • Male
  • Middle Aged
  • Receptor-CD3 Complex, Antigen, T-Cell (physiology)
  • Signal Transduction
  • T-Lymphocytes (metabolism)
  • Terpenes (pharmacology)
  • Thapsigargin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: